AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Ocular Therapeutix
OCUL
$1.86B
| $229K | ﹤0.01% |
57,900
| – | – |
|
|
CBAY
2877
DELISTED
Cymabay Therapeutics
CBAY
| $229K | ﹤0.01% |
116,800
| – | – |
|
2878
Blue Bird Corp
BLBD
$2.41B
| $227K | ﹤0.01% |
9,900
-3,900
| -28% | -$77.9K |
|
2879
SIGA Technologies
SIGA
$223M
| $227K | ﹤0.01% |
47,500
+1,500
| +3% | +$7.64K |
|
|
DSPG
2880
DELISTED
DSP Group Inc
DSPG
| $227K | ﹤0.01% |
14,450
-3,000
| -17% | -$44.2K |
|
2881
Transmedics
TMDX
$2.5B
| $226K | ﹤0.01% |
11,900
+700
| +6% | +$12.9K |
|
2882
Mistras Group
MG
$492M
| $225K | ﹤0.01% |
15,740
-2,300
| -13% | -$32.5K |
|
2883
Solid Biosciences
SLDB
$771M
| $225K | ﹤0.01% |
3,373
| – | – |
|
2884
Titan International
TWI
$516M
| $225K | ﹤0.01% |
62,100
-4,870
| -7% | -$14.5K |
|
2885
Hooker Furnishings Corp
HOFT
$148M
| $224K | ﹤0.01% |
8,700
-2,300
| -21% | -$54.1K |
|
2886
ACNB Corp
ACNB
$634M
| $223K | ﹤0.01% |
5,900
| – | – |
|
2887
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$258M
| $222K | ﹤0.01% |
+6,300
| New | +$209K |
|
|
ECOM
2888
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $222K | ﹤0.01% |
24,550
-1,600
| -6% | -$14.7K |
|
2889
Immersion
IMMR
$216M
| $221K | ﹤0.01% |
29,800
-11,900
| -29% | -$89.1K |
|
|
BREW
2890
DELISTED
Craft Brew Alliance, Inc.
BREW
| $221K | ﹤0.01% |
13,400
| – | – |
|
2891
Fossil Group
FOSL
$239M
| $219K | ﹤0.01% |
27,750
-140,040
| -83% | -$1.29M |
|
2892
Genco Shipping & Trading
GNK
$1.17B
| $219K | ﹤0.01% |
20,600
-2,600
| -11% | -$26.8K |
|
2893
Amerant Bancorp
AMTB
$1.12B
| $218K | ﹤0.01% |
10,000
| – | – |
|
2894
LCNB Corp
LCNB
$285M
| $218K | ﹤0.01% |
11,300
-200
| -2% | -$3.65K |
|
2895
Ceco Environmental
CECO
$4.42B
| $216K | ﹤0.01% |
28,200
-1,400
| -5% | -$10.5K |
|
2896
First Business Financial Services
FBIZ
$562M
| $216K | ﹤0.01% |
8,200
-200
| -2% | -$4.96K |
|
|
GDEN
2897
DELISTED
Golden Entertainment
GDEN
| $213K | ﹤0.01% |
11,100
-2,400
| -18% | -$39.3K |
|
|
FBMS
2898
DELISTED
The First Bancshares, Inc.
FBMS
| $213K | ﹤0.01% |
6,000
-1,300
| -18% | -$43.1K |
|
|
CCRD
2899
DELISTED
CoreCard
CCRD
| $212K | ﹤0.01% |
5,300
-2,000
| -27% | -$86.8K |
|
2900
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $212K | ﹤0.01% |
19,200
| – | – |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.